Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels-Reference-Cited by-同舟云学术

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

Published:2004-12 Issue:6 Volume:127 Page:1724-1732
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Zeuzem Stefan,Diago Moisés,Gane Edward,Reddy K. Rajender,Pockros Paul,Prati Daniele,Shiffman Mitchell,Farci Patrizia,Gitlin Norman,O’Brien Christopher B.,Lamour François,Lardelli Pilar

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon alfa-2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C;Manns;Lancet,2001

4. National Institutes of Health Consensus Development Conference statement: management of hepatitis C: 2002;Hepatology,2002

5. Treatment of patients with hepatitis C and normal serum aminotransferase levels;Bacon;Hepatology,2002

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection;JGH Open;2019-12-23

2. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly;PLOS ONE;2019-04-11

3. S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV) -Infektion“;Zeitschrift für Gastroenterologie;2018-06-26

4. Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes;Theranostics;2018

5. The role of biochemical variations and genotype testing in determining the virological response of patients infected with hepatitis C virus;Journal of Global Infectious Diseases;2018